Gentrack extended its slump.
Forecast ebitda range now up to A$7.5m lower.
Consultation about non-pro rata and non-renounceable share offers has yielded amended rules.
The fourth fund will be able to invest independently of local angels.
Key airport customers unhappy with scale of construction and resulting price hikes.
Airline says earnings will be no less than $580m due to high demand and falling fuel prices.
Scales predicts protein division will become bigger than Mr Apple in the long run.
Management at beleaguered company fronts. 'Without question, it’s been a very challenging few days for everybody.'
Cancer diagnostics company reveals Medicare’s coverage accounted for 77% of its total operating revenue in 2023.
Shares in trading halt pending completion of $750m underwritten placement at $9.20 a share.
